📰 Albert Bourla News
Page 22 - Albert Bourla News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Albert Bourla. Real-time updates on events, politics, business and more.
January 11, 2024
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's Wegovy and Zepbound from Eli Lilly. Amgen has an experimental dual mechanism obesity drug in mid-stage trials it hopes will have fewer side effects with less frequent dosing than Wegovy or Zepbound, Chief Scientific Officer Jay Bradner told Reuters at the annual JPMorgan health conference in San F...
January 11, 2024
China's second-in-command Li Qiang and the French president will both give special addresses.
January 11, 2024
China’s second-in-command Li Qiang and the French president will both give special addresses.
January 11, 2024
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the 
January 11, 2024
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisks...
January 11, 2024
In August, Professor Dame Jenny Harries, the head of the UK Health Security Agency (UKHSA), told Sky News: “What we’re trying to do here is ensure that we prepare so that if we have a new Disease X, a new pathogen, we have done as much of that work in advance as possible. They say they want to preve
January 11, 2024
Those flying into next week’s World Economic Forum in Davos, Switzerland are quietly rejoicing that climate activist Greta Thunberg – a notable fixture at the conference in recent years – isn’t expected to make an appearance this time around, sources told On The Money..
January 10, 2024
(CTN News) - In 2023, Pfizer had a bad year. During the 2024 J.P. Morgan Healthcare Conference, Albert Bourla, the company's CEO............
January 10, 2024
Several big pharma companies are rushing into the GLP-1 obesity space, which currently has two market leaders. How they plan to take some of that market share will be the story of the drug class for 2024.
January 10, 2024
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero